TEM Nasdaq Russell 1000 Earnings call
Tempus AI (TEM) · Q1 2026 results
Share price: $79.43 · 2026-11-11
Results Q1 2026 vs Q4 2025 · previous quarter · published 5 May 2026 and 24 Feb 2026
Net loss widened on the previous quarter, guidance raised. Management sounded about as positive as a typical company call, in its script and in answers to analysts.
Only a basic analysis is available for this company at the moment.
1 · Numbers
Loss widened
Net income vs Q4 2025
Guidance raised
Net income -125.9M vs -54.1M
Revenue −5.2%
Net income -125.9M vs -68.0M in Q1 2025 and -54.1M last quarter.
2 · How management spoke
Typical
Less upbeat than 52% of company calls
Answers to analysts: upbeat, in line with the script.
Similar to last call.
3 · What stood out
Guidance ↑
The company increased its annual revenue guidance to a range of $1.59 billion to $1.6 billion because it is on track for a great year.
Valuation
Reverse DCF. Free cash flow from the last full fiscal year, grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.
Valuation unavailable: free cash flow and profit were negative in the last full year and on average over the last three, so there is nothing to discount.
Current price
$79.43
close of 2026-11-11
Revenue growth, 3 years
+58.3% a year
compound annual rate (CAGR)
Free cash flow 2023
−$0.2B
Free cash flow 2024
−$0.2B
Free cash flow 2025
−$0.2B
Read between the lines
-
Guidance
I know it's like, whatever, now Tempus AI is going to do with, I think, its guidance is around $1.6 billion.
-
Figure
Revenue rose to $348.1 million, an increase of over 36% year-over-year, indicating growth in total sales for the quarter.
Source quote
“Revenue was $348.1 million, up a little over 36% year-over-year.”
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q4 2025.
Script and answers carried a similar tone, so the script's message held up under questioning.
Sentences that drove the tone
“Our Diagnostic revenue was $261.1 million, representing almost 35% growth, driven by particular strength in our Oncology business, which had unit growth of about 28% it was strong across the...”
“We had our third straight quarter of bookings north of $100 million, with TCV rising and visibility in the best place it's been for our Data and Apps business in...”
“And that's the benefit of having a diversified business where you've got lots of different growth engines and growth levers.”
Full figures
USD · SEC EDGAR XBRL (10-Q, period end 2026-03-31)
| Metric | Q1 2026period end 2026-03-31 | Q4 2025period end 2025-12-31 | Change | Q1 2025 | YoY |
|---|---|---|---|---|---|
| Revenue | 348.1M | 367.2M | −5.2% | 255.7M | +36.1% |
| Operating income | -84.7M | -61.4M | Loss widened | -68.7M | Loss widened |
| Net income | -125.9M | -54.1M | Loss widened | -68.0M | Loss widened |
| EPS | -0.71 | -0.31 | Loss widened | -0.40 | Loss widened |
| P/E | 12-mo loss | 12-mo loss | — | 12-mo loss | — |
Topics
Most discussed now
- New There's been some papers published recently that there's a significant volume of physicians that still aren't ordering a comprehensive…
- Tempus AI's Diagnostic revenue was $261.1 million, representing almost 35% growth, driven by particular strength in its Oncology business…
- That's the benefit of having a diversified business where you've got lots of different growth engines and growth levers.
- This quarter alone, Tempus AI added Merck, who signed a very large strategic collaboration with it.
Faded since Q4 2025
- Dropped The benefit of having a system where you're sequencing tons of patients and following mutations and you're digitizing pathology slides...
- Fading Tempus AI called out that its MRD growth rate was actually 56% quarter-over-quarter, which is extraordinary.
- Fading Tempus AI has this really unique proprietary data set that you can use to train AI, to train models.
Latest announcements
Official filings, newest first.
- Results of operations; Regulation FD disclosure · SEC 8-K
- Material agreement · SEC 8-K
- Regulation FD disclosure · SEC 8-K
- Shareholder vote results · SEC 8-K
- Material agreement; Agreement terminated; New financial obligation; Unregistered share sale; Other events · SEC 8-K
- Results of operations; Regulation FD disclosure · SEC 8-K
- Results of operations; Regulation FD disclosure · SEC 8-K
- Results of operations; Regulation FD disclosure · SEC 8-K